Negative Impact of COVID-19 Associated Health System Shutdown on Patients Diagnosed With Colorectal Cancer: A Retrospective Study From a Large Tertiary Center in Ontario, Canada

Superior Mesenteric Artery Mycotic Pseudoaneurysm Following Infective Endocarditis in a Patient With Rheumatic Heart Disease: A Case Report

We present a rare case of a 25-year-old woman with rheumatic heart disease who developed a superior mesenteric artery pseudoaneurysm (SMAPA) following infective endocarditis (IE). Initially, she presented with chest pain, dyspnea, and fever, leading to the diagnosis of IE and severe mitral regurgitation. After six weeks of antimicrobial therapy, she developed persistent abdominal pain. Further evaluation revealed a mycotic SMAPA, which was successfully treated with open surgical repair. Postoperatively, her abdominal pain improved significantly, and she was discharged on postoperative day five. The current case underscores the importance of maintaining a high index of suspicion for mycotic pseudoaneurysms in patients with risk factors, even when they present with nonspecific symptoms. The findings also highlight the critical role of computed tomography angiography (CTA) in accurate diagnosis and preoperative planning. The favorable outcome supports current guidelines for managing mycotic SMA pseudoaneurysms in complex scenarios, emphasizing the need for adherence to established protocols and recommendations.

Delivery and Prioritization of Surgical Care in Canada During COVID-19: An Environmental Scan

BACKGROUND

During COVID-19 healthcare systems had to make concessions to make room for the surge of COVID-19 patients requiring hospital and intensive care. Postponing surgeries was a common strategy; however, it is unclear how surgical care was delivered during this time of constraint. The objective of this study was to understand how surgical care was delivered and prioritized during the COVID-19 pandemic response.

METHODS

This was an environmental scan following the Canadian Agency for Drugs and Technologies in Health methodology. This study was conducted in Canada; a universal, publicly funded healthcare system. Evidence sources on policies pertaining to the provision of surgical care between January 2020 and October 2022 were obtained from ministries of health, health services agencies and publicly funded hospitals across all 10 provinces and three territories. We synthesized the evidence sources using framework analysis.

RESULTS

We identified 205 evidence sources that described six themes about the provision of surgical care during the COVID-19 pandemic: the cycle of postponement and resumption; guidelines for triaging and prioritizing surgical cases; Infection Prevention and Control (IPAC), and safety measures for surgical care during COVID-19, patient-centred care, and looking forward (recovery planning, leadership, and decision-making).

CONCLUSION

This study provides a comprehensive understanding of how surgical care was disrupted and innovated during COVID-19 which can inform future strategies for providing effective and efficient surgical care during times of healthcare constraint.

COVID-19 Impact on Diagnosis and Staging of Colorectal Cancer: A Single Tertiary Canadian Oncology Center Experience

Background: Public health measures have imposed drastic reductions in cancer screening programs at the beginning of the COVID-19 pandemic, with an unknown impact on the diagnosis and staging of colorectal cancer (CRC). Methods: Newly diagnosed CRC cases at the Centre Hospitalier de l’Université de Montréal (CHUM) were divided into two groups according to the timeline: pre-pandemic (1 January 2018–12 March 2020), and pandemic (13 March 2020–30 June 2021) periods. Colonoscopy, surgery, and staging at diagnosis during the pandemic period were compared to the pre-pandemic period. Results: 254 CRC diagnoses were made during the pre-pandemic period in comparison to 125 during the pandemic period. Mean diagnosis rates were lower in the pandemic period (7.8 vs. 9.8 diagnoses/month, p = 0.048). Colonoscopy deadlines were less respected in the pandemic period (51.7% vs. 38.3%, p = 0.049). The rate of elective surgery did not differ (2.9 vs. 3.5 surgeries/month, p = 0.39) and mean delays were similar (58.6 vs. 60.4 days, p = 0.77). Stages at diagnosis did not differ (p = 0.17). Most of the delayed colonoscopies led to a stage 0 or I CRC (p = 0.2). Conclusion: In our center, the COVID-19 pandemic resulted in a decreased rate of CRC diagnosis and increased endoscopic delays without affecting the rate of advanced stage disease. Delays to surgery were quite similar once the CRC diagnosis was established.